Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
US names Rubio, Tony Blair to Gaza board under Trump's plan
Uganda's Museveni wins re-election, opposition leader at large
Protesters in Denmark support Greenland after Trump's takeover threat
Egypt's Sisi says he values offer by Trump to mediate Nile dam dispute
Ukrainian team heading to US for security guarantee talks, Zelenskyy says
